Cell & Gene Therapies: FDA Regulatory Considerations In 2024
The fact is that most in the biotech industry know that cell and gene therapies-...
Can Clinical Research Spectrum Make The Most of Gene Therapy
It is a well-established fact that gene therapy research happens to be booming. Since the...
US Enacts Biosecurity Law Blocking Chinese Bio Company Deals
In March 2024, one of the biosecurity laws restricting transactions with Chinese bio companies happened...
Market Trends: Biologics Clinical Manufacturing CDMO Service
In the ever-changing pharma and biologics sector, the Biologics Clinical Manufacturing CDMO Service market has...
CDMOs Offering Unique Options To Meet Cold Chain Demands
It is worth noting that the Cell and gene therapies- CGTs have gone on to...
Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY can help to close...
UCB, a global biopharmaceutical company announced key findings from the first retrospective patient cohort study...
Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions
Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announces its acquisition of Insife...
Precision Lab Equipment Has IoT As Its Biggest Partner
It is well to be noted that precision happens to be one of the most...
Digital Pharma Labs of The Future – Holding Immense Promise
Pharmaceutical labs happen to work with data. Immense data which needs to be stored, assessed,...
Drug Delivery – Switchable Peptide-Stabilized Emulsions
A new study which has been led by Prof. Meital Reches from the Hebrew University,...
